Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

936
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
936
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

710
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
710

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Notice to: Stem cell and colorectal carcinogenesis.

Journal of medicine and life·2023
Same author

Colorectal Chemoprevention.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018
Same author

[Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2017
Same author

Stem cells and colorectal carcinogenesis.

Journal of medicine and life·2016
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same journal

Healthcare costs of COVID-19 hospitalization in maintenance hemodialysis patients during the first two pandemic waves in Romania: a retrospective cohort study.

Journal of medicine and life·2026
Same journal

Clinical and inflammatory biomarkers predicting emergency surgical management decisions and postoperative outcomes in complicated colon cancer.

Journal of medicine and life·2026
Same journal

Antibiotic stewardship and safety in office-based transrectal prostate biopsy: a single-center retrospective analysis of complications.

Journal of medicine and life·2026
Same journal

Epigenetic mechanisms in preeclampsia: translational therapeutic strategies and precision-medicine perspectives.

Journal of medicine and life·2026
Same journal

Short-term functional outcome and pain assessment after spinal decompression for spondylodiscitis.

Journal of medicine and life·2026
Same journal

Effects of vitamin K administration on liver function, inflammation, and coagulation in chronic viral hepatitis: a retrospective study.

Journal of medicine and life·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.3K

Biomarkers in Rheumatoid Arthritis, what is new?

B I Gavrilă1, C Ciofu1, V Stoica1

  • 1Department of Internal Medicine and Rheumatology, "Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Journal of Medicine and Life
|July 26, 2016
PubMed
Summary
This summary is machine-generated.

Discovering new biomarkers is crucial for early rheumatoid arthritis (RA) diagnosis and predicting treatment response. Identifying aggressive RA forms and non-responders aids personalized patient management.

Keywords:
biologic therapybiomarkersdisease activityrheumatoid arthritis

More Related Videos

Automated Joint Space Detection Improves Bone Segmentation Accuracy
06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

257
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 17, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.3K
Automated Joint Space Detection Improves Bone Segmentation Accuracy
06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

257
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Area of Science:

  • Rheumatology and immunology research.
  • Biomarker discovery and validation.
  • Autoimmune disease pathogenesis.

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting joints and systemic manifestations.
  • Current diagnostic criteria (EULAR 2010) rely on rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies.
  • Existing disease activity scores (DAS28, SDAI, CDAI) guide treatment, but new monitoring tools are emerging.

Purpose of the Study:

  • To explore the evolving landscape of rheumatoid arthritis biomarkers.
  • To highlight the need for biomarkers in early diagnosis, prognosis, and treatment selection.
  • To address the challenge of identifying non-responders to biological therapies.

Main Methods:

  • Review of current diagnostic and prognostic biomarkers for RA.
  • Discussion of novel biomarkers for early detection and disease monitoring.
  • Analysis of the role of biomarkers in predicting response to biological therapies.

Main Results:

  • Biomarkers like anti-CCP have improved early RA diagnosis since 2010.
  • Prognostic biomarkers are essential for identifying aggressive RA forms.
  • Newer tests, including multi-biomarker disease activity (MBDA) tests, offer improved disease monitoring.
  • Identifying non-responders to biologics remains a challenge, necessitating further biomarker research.

Conclusions:

  • Biomarkers are critical for advancing rheumatoid arthritis diagnosis, prognosis, and personalized treatment.
  • Continued research into novel biomarkers is needed to optimize patient outcomes and reduce healthcare costs.
  • Identifying patients likely to benefit from specific therapies will improve the efficacy of rheumatoid arthritis management.